Spatial-DC maps a candidate fibroblast–cancer signaling interaction in pancreatic tumors
Spatial-DC reconstructed cell-type-resolved spatial proteomes and suggested COL8A1–ITGA2 communication between cancer-associated fibroblasts and pancreatic cancer cells. Multiplexed immunohistochemistry supported the spatial predictions; human protein co-expression was associated with survival. The pairing was already known: the result concerns its inferred spatial deployment, not a new receptor pair or established causal mechanism. This record uses the May 27, 2026 journal version; the result already appeared in the December 20, 2024 preprint.
Technology: Spatial-DC; graph-enhanced transfer learning
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Retrospective spatial proteomic reconstruction and human survival association. Same-study multiplexed immunohistochemistry supports spatial distributions and co-expression, not causal COL8A1–ITGA2 communication.
- Still unknown: No causal signaling perturbation, therapeutic benefit or independent replication is established in the reviewed material. Current review read indexed publisher introduction and NLM abstract/metadata; full journal methods were inaccessible. Earlier primary preprint XML was read in the project audit on November 16, 2026; revised journal quantitative details were not assessed.
- AI role: Graph-enhanced transfer learning deconvolved mixed spots and reconstructed cell-type-resolved protein profiles used to infer spatial interactions.
Evidence sources: https://www.sciencedirect.com/science/article/abs/pii/S2405471226000943 · https://pubmed.ncbi.nlm.nih.gov/42202779/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.